Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Open Access
- 1 June 1988
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 51 (6) , 850-854
- https://doi.org/10.1136/jnnp.51.6.850
Abstract
Twenty six consecutive patients with neuroleptic-induced Parkinson's syndrome (NIPS) are described. Their median age was 61 years, 60% were female, and most had received chronic neuroleptic medication for psychiatric indications. The clinical features were indistinguishable from idiopathic Parkinson's disease, except for the presence of co-existing orofacial chorea, limb dyskinesia or akathisia which provided an aetiological clue in 11 cases. Complete resolution of NIPS occurred in only two patients, one of whom later developed Parkinson's disease. Sixteen patients were treated with 300-1000 mg levodopa/benserazide for up to 4 years with few adverse effects but therapeutic response was disappointing.This publication has 38 references indexed in Scilit:
- Extrapyramidal disturbances caused by inappropriate prescribing.BMJ, 1987
- Drug induced parkinsonism.BMJ, 1986
- EXTRAPYRAMIDAL SIDE-EFFECTS OF METOCLOPRAMIDEThe Lancet, 1978
- Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind PlaceboBMJ, 1973
- Behavioral effects of l-Dopa in schizophrenic patientsPsychopharmacology, 1973
- Prolonged Drug-Induced ParkinsonismStereotactic and Functional Neurosurgery, 1973
- Effect of L‐Dopa in SchizophreniaPsychiatry and Clinical Neurosciences, 1972
- Trial of Maintenance Therapy in SchizophreniaBMJ, 1971
- L-DOPA IN DEPRESSED PATIENTSThe Lancet, 1970
- EFFECTS OF L‐DOPA ON PHARMACOLOGICAL PARKINSONISMActa Psychiatrica Scandinavica, 1966